ProFound Therapeutics rings in $75m

ProFound Therapeutics, a a human proteome biotech startup, has raised $75 million in funding.

26 May 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.